‘Vials at fake vax centres not Covishield’

Kolkata: Serum Institute on Thursday confirmed that all the vials purportedly passed off as Covishield by fake IAS officer Debanjan Deb at his ‘vaccination camps’ were not genuine.

In a written reply to detective department, the manufacturer of Covishield stated that none of the specimens sent to them by police (those seized from Deb’s Kasba office) matched their own batch numbers. The manufacturer has also stated that none of the seized vials were manufactured in their units.

“They have confirmed that the vials are fake. We had written to them about the content inside them. This will bolster the cases against Deb,” said joint CP (crime) Murlidhar Sharma. The cops though said that this was not enough to ascertain the “actual” medicine contained in the vial, which is widely believed to be Amikacin. “We have sent samples to the drug control office for chemical examination. We are still awaiting the final reports,” said a police source.

  • Related Posts

    WHO launches new primary health care course to strengthen health systems globally

    Health is a human right – yet not everyone can access the health services they need, when and where they need them, without financial hardship. Primary health care (PHC) provides…

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    WHO launches new primary health care course to strengthen health systems globally

    WHO launches new primary health care course to strengthen health systems globally

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert